Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Structure meets function for OATP1B1, a transporter involved in the uptake of endogenous and xenobiotic materials and drugs

Award Number: R01GM149871
ORGANIZATION: NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 04/01/2023
PERIOD OF PERFORMANCE END DATE: 02/28/2027

Group Awards By:

View Award Description

Structure meets function for OATP1B1, a transporter involved in the uptake of endogenous and xenobiotic materials and drugs - Project summary The polymorphic transporter OATP1B1 plays significant roles in the hepatic uptake and disposition of endogenous molecules and drugs. Further, OATP1B1 is involved in numerous drug-drug interactions (DDIs) due to its multispecificity. Despite decades of research, many factors related to the determinants of ligand binding, transport mechanism and energetics, as well as the structure of this important transporter are unresolved. The long-term goal is to characterize hepatic transport at the microscopic and macroscopic levels. Due to the functional importance of OATP1B1 in liver clearance, this is the first target studied. The central hypothesis is that structures of human OATP1B1 and functional assays performed on isolated proteins will unequivocally define the mechanism of ligand binding, transport, and inhibition. The rationale that underlies this research is that protein structures coupled with unambiguous, reproducible activity assays are absolutely required to fully characterize the mechanism of transport and resolve long-standing conflicting data reported in the literature. Establishing robust expression and purification protocols for human OATP1B1 facilitates pursuing the two Specific Aims: 1) Resolve structures of OATP1B1 by Cryo-EM and analyze their motions by MD simulations. 2) Functionally characterize the transport mechanism of OATP1B1. For the 1st Aim, the optimal conditions that result in the highest image quality for Cryo-EM of OATP1B1 would be screened, and data would be acquired in the presence and absence of ligands. The Cryo-EM studies will be augmented by MD simulations and docking studies that would reveal details that are not accessible by mere structural analysis. The different biochemical conditions (apo and holo) increase the likelihood of A) solving the structural determinants of the binding of various ligands (with distinct chemistries) to the two ligand-binding sites of OATP1B1. B) solving the structures of multiple conformations that are part of the transport cycle. For the 2nd Aim, we will use purified protein reconstituted into proteoliposomes to characterize the inherent properties of OATP1B1 such as the energizing ion for transport, the influence of the membrane voltage, and pH. Those results would be compared with cellular assays that include intact cellular machinery, and other plasma membrane transporters that might directly or indirectly affect OATP1B1. The research proposed in this application is innovative, in the applicant’s opinion because it introduces two methodologies that have never been explored for any OATP isoform. These could uncover a plethora of novel insights into the structure/function relationship of OATP1B1. The proposed research is significant since OATP1B1 is involved in DDIs of several commonly prescribed drugs, sometimes resulting in life-threatening situations. This study would unravel the exact determinants of ligand binding to OATP1B1 and transport. Ultimately, the structural and functional knowledge generated here has the potential to aid in the design of drugs that exhibit a lower propensity for DDIs.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $425,028 )
2026	2026	THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK	520 LEE ENTRANCE STE 211	AMHERST	NY	14228	ERIE	USA	Biomedical Research and Research Training	000	5	2/18/2026	NON-COMPETING CONTINUATION	$425,028
														Subtotal = $425,028

Issue Date FY: 2025 ( Subtotal = $405,740 )
2025	2025	THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK	520 LEE ENTRANCE STE 211	AMHERST	NY	14228	ERIE	USA	Biomedical Research and Research Training	003	4	9/2/2025	NON-COMPETING CONTINUATION	$430,383
2025	2024	THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK	520 LEE ENTRANCE STE 211	AMHERST	NY	14228	ERIE	USA	Biomedical Research and Research Training	002	3	7/17/2025	CHANGE OF GRANTEE / TRAINING INSTITUTION / AWARDING INSTITUTION	$194,630
2025	2024	HAUPTMAN WOODWARD MEDICAL RESEARCH INSTITUTE, INC	700 ELLICOTT ST # 700	BUFFALO	NY	14203	ERIE	USA	Biomedical Research and Research Training	004	2	9/8/2025	NON-COMPETING CONTINUATION	$0
2025	2024	HAUPTMAN WOODWARD MEDICAL RESEARCH INSTITUTE, INC	700 ELLICOTT ST # 700	BUFFALO	NY	14203	ERIE	USA	Biomedical Research and Research Training	000	2	7/17/2025	NON-COMPETING CONTINUATION	-$140,164
2025	2024	HAUPTMAN WOODWARD MEDICAL RESEARCH INSTITUTE, INC	700 ELLICOTT ST # 700	BUFFALO	NY	14203	ERIE	USA	Biomedical Research and Research Training	001	2	7/17/2025	SUPPLEMENT FOR EXPANSION	-$79,109
														Subtotal = $405,740

Issue Date FY: 2024 ( Subtotal = $687,013 )
2024	2024	HAUPTMAN WOODWARD MEDICAL RESEARCH INSTITUTE, INC	700 ELLICOTT ST # 700	BUFFALO	NY	14203	ERIE	USA	Biomedical Research and Research Training	000	2	2/8/2024	NON-COMPETING CONTINUATION	$395,240
2024	2024	HAUPTMAN WOODWARD MEDICAL RESEARCH INSTITUTE, INC	700 ELLICOTT ST # 700	BUFFALO	NY	14203	ERIE	USA	Biomedical Research and Research Training	002	2	9/17/2024	SUPPLEMENT FOR EXPANSION	$247,859
2024	2024	HAUPTMAN WOODWARD MEDICAL RESEARCH INSTITUTE, INC	700 ELLICOTT ST # 700	BUFFALO	NY	14203	ERIE	USA	Biomedical Research and Research Training	001	2	6/10/2024	NON-COMPETING CONTINUATION	$43,914
														Subtotal = $687,013

Issue Date FY: 2023 ( Subtotal = $483,347 )
2023	2023	HAUPTMAN WOODWARD MEDICAL RESEARCH INSTITUTE, INC.	700 ELLICOTT ST	BUFFALO	NY	14203	ERIE	USA	Biomedical Research and Research Training	000	1	3/27/2023	NEW	$483,347
														Subtotal = $483,347

Grand Total All Awards = $2,001,128

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Structure meets function for OATP1B1, a transporter involved in the uptake of endogenous and xenobiotic materials and drugs

Award Number: R01GM149871

ORGANIZATION: NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 04/01/2023

PERIOD OF PERFORMANCE END DATE: 02/28/2027

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer